Showing results (91-100 of 428) with videos related to
Sort By:
Pageof 43
Bioscience Reports|October 1, 1992
Carboxyterminal telopeptide of type I collagen, ICTP, as a marker of matrix degradation in neonatal mouse calvarial bones, in vitroO Ljunggren, S LjunghallOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 1, 1994
Distal radius fracture is an early sign of general osteoporosis: bone mass measurements in a population-based studyH Mallmin, S LjunghallUpsala Journal of Medical Sciences|January 1, 1990
Hypercalcemia in pulmonary tuberculosisL Lind, S LjunghallCurrent Opinion in General Surgery|January 1, 1993
Medical and radiologic evaluation and operative treatment of primary hyperparathyroidismG Akerström, S LjunghallUpsala Journal of Medical Sciences|January 1, 1985
Lipid-lowering effects of two synthetic oestrogen derivatives with weak genital oestrogen propertiesG Herbai, S LjunghallBiochemical and Biophysical Research Communications|June 30, 1993
The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitroO Ljunggren, S LjunghallBiochemistry and Molecular Biology International|February 1, 1996
Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblastsH Melhus, S LjunghallJournal of Electrocardiology|April 1, 1994
Serum calcium and the ECG in patients with primary hyperparathyroidismL Lind, S LjunghallUrologia Internationalis|January 1, 1983
Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicityG Herbai, S LjunghallExperimental and Clinical Endocrinology|January 1, 1994
Blood pressure reaction during the intraoperative and early postoperative periods in patients with primary hyperparathyroidismL Lind, S LjunghallPageof 43